Pfizer cuts outlook, profits slump; Lilly ekes out a gain

... Ventura County Star: Business The Ventura County Star Network: Autos Real Estate Classifieds Jobs Register Market Movers » Winners » Losers Market Summary Mutual funds PR Newswire Stock alerts Your Portfolio PRINT THIS STORY | E-MAIL THIS STORY Pfizer cuts outlook, profits slump; Lilly ekes out a gainBy Theresa Agovino, and Ashley M.

Heher, AP business writersOctober 21, 2005NEW YORK - Pfizer Inc., the world's biggest drug company, said Thursday its third-quarter earnings plunged 52 percent and a sluggish sales outlook for key drugs like pain reliever Celebrex and Viagra prompted it to cut profit estimates for this year and withdraw guidance beyond that.

Its shares slumped to their lowest level in almost a decade.

Profits at competitor Eli Lilly & Co.

rose 5 percent in the third quarter, but it said sales of its top-selling product, the anti-psychotic drug Zyprexa, rose only 1 percent.

And MedImmune Inc., the maker of FluMist nasal spray va...

Read more...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news